首页> 外文期刊>Chinese Jouranl of Integrative Medicine >A Clinical Study on the Effect of Yinxing Damo Combined with Betahistine Hydrochloride Injection on Vertebral Basilar Artery Ischemic Vertigo
【24h】

A Clinical Study on the Effect of Yinxing Damo Combined with Betahistine Hydrochloride Injection on Vertebral Basilar Artery Ischemic Vertigo

机译:银杏达莫联合盐酸倍他司汀注射液治疗椎基底动脉缺血性眩晕的临床研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To evaluate the therapeutic efficacy of Yinxing Damo (YXDM) combined with Betahistine Hydrochloride Injection (BHI) on vertebra basilar artery ischemic vertigo (VBIV). Methods; Ninety patients with VBIV were randomly divided into two groups; 45 patients (the treated group) were treated with YXDM and BHI intravenous dripping, once a day for 14 days. Another 45 patients (control group) were treated with Xueshuantong and BHI intravenous dripping, once daily for 14 days. The clinical syndromes and the index of the transcranial Doppler (TCD) and hemorheology were observed. Results : The total effective rate was 100% in the treated group, which was better than that in the control group 90.5%, (P < 0.05). The indexes of TCD and hemorheology in the treated group were obviously improved after treatment, (P < 0.01). Conclusion: YXDM combined with BHT injection had better effect in treating patients with VBIV is an ideal drug for VBIV.
机译:目的:评价银杏达莫(YXDM)联合盐酸倍他司汀注射液(BHI)治疗椎基底动脉缺血性眩晕(VBIV)的疗效。方法; 90例VBIV患者被随机分为两组。 45例患者(治疗组)接受YXDM和BHI静脉滴注治疗,每天一次,持续14天。另有45例患者(对照组)接受血栓通和BHI静脉滴注治疗,每天一次,持续14天。观察临床症状,经颅多普勒指数(TCD)和血液流变学指标。结果:治疗组总有效率100%,优于对照组的90.5%(P <0.05)。治疗组TCD指标和血液流变学指标较治疗后有明显改善(P <0.01)。结论:YXDM联合BHT注射液治疗VBIV疗效更好,是治疗VBIV的理想药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号